Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genomic Valley Biotech has submitted the disclosure of Related Party Transactions for the half year ended 30.09.2022.
The above information is a part of company’s filings submitted to BSE.